Isentress 400 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FQT7B
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $315,452
Award facts
- Contract value 100% obligated
- $315,452.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $315,452.35 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of 60-count bottles of Isentress 400 mg tablets, with an ultimate completion date of January 7, 2026. This competitively awarded, non-set-aside contract was executed on January 6, 2026, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. Isentress (raltegravir) is an antiretroviral medication used in the treatment of HIV infection and reflects the Defense Logistics Agency's ongoing pharmaceutical procurement needs to support military healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive pharmaceutical supply vehicle valued at up to $999,999,999.00 through December 31, 2031. The IDC enables Cencora to supply a broad spectrum of pharmaceutical products, medical devices, and healthcare commodities—including specialty medications, vaccines, and medical supplies—to support military treatment facilities and other federal healthcare programs globally. AmerisourceBergen's established role as a major pharmaceutical distributor and its competitive positioning within the federal medical procurement landscape make it a critical vendor for fulfilling military healthcare pharmaceutical requirements.
Quick answers
Who was awarded contract SPE2DR26FQT7B?
SPE2DR26FQT7B was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FQT7B worth?
The government has obligated $315,452 on SPE2DR26FQT7B.
Is contract SPE2DR26FQT7B an order under another contract?
Yes. SPE2DR26FQT7B is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQT7B competed?
The extent of competition for SPE2DR26FQT7B was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award